The Vaughan Nelson Global Equity SMID Fund (Quoted Managed Fund) (ASX: VNGS) (“VNGS” or the “Fund”) is an Exchange Traded Managed Fund (ETMF) that listed in June 2022. The Fund provides exposure to the Vaughan Nelson Global SMID Cap strategy, which has an inception date of June 2020. The Fund is the quoted class of the investment strategy with the …

We have completed an update report for Acurx following the release of the September quarterly results and business update on 13 November 2024. The key takeaways are: Phase 3 Trial Design and Manufacturing Signed-Off: The Company had a Chemistry, Manufacturing and Controls (CMC) meeting with the FDA scheduled for October, however the meeting was not needed due to the FDA …

WAM Global Limited (ASX: WGB) is a listed investment company (LIC) that listed on the ASX in June 2018. The Company provides exposure to an actively managed, benchmark unaware portfolio of global securities with the objective of generating superior risk-adjusted returns to the market over the medium-to-long term. The portfolio is managed by Wilson Asset Management (International) Pty Ltd (the …

The Pharma & Biotech market had a relatively muted month. There were a number of companies that experienced strong share price movements but this was on limited newsflow and limited liquidity. In this edition of Movers & Shakers we take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

In this edition of the LMI Monthly Update we take a look at the key news items and announcements during October, which included the commencement of trading of MRE and a new LIC coming to market. We also take a look at the state of play of premiums/discounts across a range of categories, with the current environment providing a number …